PATENT CLAIM ANALYSIS

Application Number: 15749558
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "04400A"]

Abstract:
A method of treating cancer in a subject is disclosed. The method comprises administering to the subject: (i) a therapeutically effective amount of an inhibitory agent that down-regulates an amount of a polypeptide selected from the group consisting of BCL-2, MCL-1 and cyclin D1; and (ii) a therapeutically effective amount of a CXCR4 binding agent that increases the expression of miR-15a and/or 16-1, thereby treating the cancer.

Claim (Index 27):
The method of  claim 26 , wherein the cancer is a hematological cancer.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 88.0
- Lexical Diversity: 1.57143
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15007002', '12978086', '13881695', '14988275', '13806929']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7727401994123771
- 35 USC 102 Novelty (BERT): 0.5217707308946312
- Combined Prediction Score: 0.7476432525606025
- Mean Citation Score: 261.351658
- Max Citation Score: 276.67712
- Similarity Product: 155.31802465835568

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test